Cost-effective proton therapy systems
ProTom Asia (protominternational.com) earns a Brand Analyzer score of 66 out of 100, placing it in the Developing tier among Healthcare brands, Technology brands, Manufacturing brands. Among 4778 Healthcare brands analyzed, ProTom Asia ranks in the 20th percentile (category average 74, leader 96). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 93/100, Digital Presence 88/100, Visual Identity 94/100, Messaging Clarity 95/100, Trust Foundation 66/100, AI Discoverability 27/100, Brand Authority 17/100.
ProTom Asia Limited is the exclusive regional licensee of ProTom International (USA), authorized to bring FDA-cleared proton therapy technology, intellectual property, and manufacturing capabilities to China (including Hong Kong, Macau, Taiwan), North and South Asia, the Middle East, and Africa. The company focuses on providing cost-effective, commercially viable proton therapy systems to expand access to advanced cancer treatment in these regions, targeting hospitals, healthcare investors, medical institutions, and government health agencies.
| Brand Name | ProTom Asia |
|---|---|
| Domain | protominternational.com |
| Industry | Healthcare, Technology |
| Main Competitors | IBA (Ion Beam Applications) (67/100), Varian (Siemens Healthineers) (85/100), Hitachi (86/100), Mevion Medical Systems, Sumitomo Heavy Industries, Elekta (89/100) |
Moz Domain Authority 25/100 vs category average 38 / leader 95 - limited third-party links, so AI systems rarely encounter mentions of the brand.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "ProTom Asia Limited is the exclusive licensee of ProTom International of USA for territories of : China (including Hong Kong, Macau and Taiwan), North Asia. South Asia, the Middle …" (Meta description: 54 words. No OG description (falling back to meta)) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: No structured data or Open Graph tags detected. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: No robots.txt found (default: all bots allowed, but explicit file preferred) - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on Instagram, YouTube; no detected presence on X (Twitter), LinkedIn, Facebook, GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
ProTom Asia scores 10/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
ProTom Asia has a weak AI-visibility profile at 10/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (27/100) and its weakest is visibility (0/100). It benefits from open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, no strong Wikidata entry and a low Moz Domain Authority of 25/100. In a live check, Claude could already identify ProTom Asia from memory (August 2026) - a sign these signals are paying off.
Live results from asking a general-purpose AI assistant about the brand, checked August 2026.
When asked "What is ProTom Asia?", Claude could identify the brand as of August 2026. ProTom Asia is the Asian regional arm of ProTom International, a company known for developing compact proton therapy systems, such as the Radiance 330, used in cancer treatment centers. Best known for compact proton beam therapy systems for cancer treatment.
When asked "Best brands similar to ProTom Asia?", Claude would recommend ProTom Asia as of August 2026. If someone asked about proton therapy equipment makers, ProTom is a recognizable name alongside bigger players like Varian and IBA, so it's worth mentioning.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
ProTom Asia's main competitors include IBA (Ion Beam Applications) (67/100), Varian (Siemens Healthineers) (85/100), Hitachi (86/100), Mevion Medical Systems, Sumitomo Heavy Industries. These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: Brand Analyzer scan
ProTom Asia and Elekta are competitors in Healthcare. Brand Analyzer scores ProTom Asia at 66/100 and Elekta at 89/100. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: Brand Analyzer scan
Popular alternatives to ProTom Asia include IBA (Ion Beam Applications) (67/100), Varian (Siemens Healthineers) (85/100), Hitachi (86/100), Mevion Medical Systems, Sumitomo Heavy Industries. Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: Brand Analyzer scan
ProTom Asia offers proton therapy systems based on FDA-cleared technology licensed from ProTom International of the USA. Its services include manufacturing, assembly, and testing of these systems, along with the associated intellectual property and technology transfer needed to establish proton therapy capabilities in hospitals and medical institutions across its licensed territories.
Sources: ProTom Asia official site
ProTom Asia is a company holding the exclusive license from ProTom International of the USA to distribute, manufacture, assemble, and test proton therapy systems in China (including Hong Kong, Macau, and Taiwan), North Asia, South Asia, the Middle East, and Africa.
Sources: ProTom Asia official site
ProTom Asia has low AI-search visibility, scoring 10/100 on Brand Analyzer's AI visibility composite (visibility 0, trust 12, recommendation 27). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: ProTom Asia official site
ProTom Asia licenses and deploys FDA-cleared proton therapy technology from ProTom International in its designated territories. Its activities include manufacturing, assembly, and testing of proton therapy systems, along with providing long-term service contracts to reduce investor and technical risk for hospitals and healthcare providers seeking advanced cancer treatment infrastructure.
Sources: ProTom Asia official site
ProTom Asia scores 27/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: ProTom Asia official site
ProTom Asia can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: ProTom Asia official site
ProTom Asia's offerings are used by hospitals, medical institutions, healthcare investors, and government health agencies across China (including Hong Kong, Macau, and Taiwan), North and South Asia, the Middle East, and Africa that seek to establish or expand advanced cancer treatment infrastructure using proton therapy technology.
Sources: ProTom Asia official site
ProTom Asia is known for being the exclusive regional licensee of ProTom International's FDA-cleared proton therapy technology across China, North and South Asia, the Middle East, and Africa, and for enabling access to this advanced cancer treatment technology through localized manufacturing and service support.
Sources: ProTom Asia official site
Ranked closest to ProTom Asia: Pixalere (66/100), PhysioOutaouais (66/100), Provide Enterprise (66/100), Purple Life Sciences (66/100).
A step up - brands to learn from: Zipari by mPulse (71/100), Zaina AI (71/100).
Category leader: Elsevier (96/100).